Description
An inhibitor of MDMX; decreases MDMX promoter activity in a reporter assay in a concentration-dependent manner; decreases the expression and protein levels of MDMX and increases the expression of the p53 target gene CDKN1 (p21) in MCF-7 cells overexpressing MDMX at 5 µmol/L; induces apoptosis and decreases cell viability in MCF-7 cells in a p53-dependent manner at 5 µmol/L; induces p53-independent apoptosis in wild-type, mutated, and truncated p53 Ewing sarcoma cell lines (IC50s = 98.9-1,613, 236-299, and 121-396 nM, respectively) selectively over wild-type and p53-null osteosarcoma cells (IC50s = 3,690-5,416 and 2,143 nM, respectively)
Formal name: 4-(4-methyl-1-piperazinyl)-7-nitro-2,1,3-benzoxadiazole, 3-oxide
Synonyms: NSC 179940|XI-006
Molecular weight: 279.3
CAS: 58131-57-0
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Cancer|Cell Signaling|p53 Signaling||Research Area|Cancer|Transcription Factors|p53